In this issue of Surgical Oncology Clinics, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of Hepatocellular Carcinoma. Top experts in the field explore promising recent advances in the treatment of all stages of hepatocellular carcinoma (HCC), neoadjuvant or downstaging therapy, the role of LI-RADS in hepatocellular carcinoma, surveillance of hepatocellular carcinoma, liver transplantation, and more.
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach Overview of Current Hepatocellular Carcinoma Staging Systems: Is There an Optimal System? Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma Up-to-Date Role of Liver Imaging Reporting and Data System in Hepatocellular Carcinoma Evolution of Systemic Therapy in Advanced Hepatocellular Carcinoma Role of Neoadjuvant Therapy Prior to Curative Resection in Hepatocellular Carcinoma Expanding Indications for Surgical Resection in Hepatocellular Carcinoma: What is the Evidence? Minimally Invasive Robotic Techniques for Hepatocellular Carcinoma Resection: How I Do It Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma Downstaging Hepatocellular Carcinoma before Transplantation: Role of Immunotherapy Versus Locoregional Approaches Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.